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OBJECTIVE: To improve understanding of the hemodynamic status of patients with sepsis by nursing teams through the attainment
of hemodynamic parameters using a pentaxial “target” diagram as a clinical tool. Parameters include cardiac index (CI), arterial
oxygen saturation (SaO2), mean arterial pressure (MAP), arterial blood lactate, and central venous oxygen saturation (ScvO2).
METHODS: Design: Prospective descriptive study. Setting: The intensive care unit of a university hospital. Patients: During a 6-
month period, 38 intubated septic shock patients were included in the study. Survivors and nonsurvivors were compared. Interventions:
MAP, CI, SaO2, ScvO2 and lactate were measured at 0, 6, 12, 24, 36, and 48 h. Measurements were recorded on the target diagram
along with the norepinephrine infusion rate and the hemoglobin (Hb) level. The number of lactate and ScvO2 measurements achieved
during the target period were compared to a 6-month retrospective control period just before starting the protocol. We assessed the
nurse knowledge status prior to the introduction of target diagram. We then performed a post-test after implementing the new
recording technique.
MEASUREMENTS AND RESULTS: The nursing team expressed a positive attitude toward the target concept. The mean
number of lactate and ScvO2 measurements performed for each patient during the control period was significantly lower than during
the target period, and those values were rarely used as goal values before the introduction of the target diagram. At 24 hours, 46%
of the survivors had achieved all the goal parameter values of the target diagram, compared to only 10% of nonsurvivors (P = .01).
CONCLUSION: The target diagram is a visual multiparametric tool involving all the medical and nursing team that helps achieve
goal-directed therapy for septic patients. The number of goal values reached at each time point during the first 48 hours was closely
linked to mortality.
KEYWORDS: Guidelines translating. Clinical practice. Septic patients. End Point. Target tool
INTRODUCTION
The early diagnosis and treatment of septic patients is
currently an important public health issue because of the
high incidence and mortality rate of severe sepsis.1 A world-
wide campaign has been carried out since 2004 with the
aim of conveying the right therapeutic attitudes in order to
improve the prognosis of septic patients.2 Now, physicians
are facing a new challenge, ie, how to translate science to
practical application.3,4 In order to help the physician, au-
thors try to define tools to synthesize evidence for use in
bedside practice, helping to reduce variations and uncer-
tainty in practice.5 Hollenberg et al6 argue that for
hemodynamic management, it is fundamental that clini-
cians define specific goals and end points, titrate therapies
to those end points, and continually evaluate the results of
their interventions by monitoring multiple variables of glo-
bal and regional perfusion.
To achieve this end, like Shoemaker in the 1980s,7 we
have designed a target diagram to visualize the hemodynamic
goals of septic patients. These parameters reflect oxygen de-
livery (cardiac index - CI, arterial oxygen saturation - SaO2,
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and hemoglobin - Hb); tissue perfusion (mean arterial pres-
sure - MAP); oxygen tissue extraction (central venous oxy-
gen saturation - ScvO2); and cellular ischemia (blood lac-
tate concentration) (Figure 1). The central grey area on the
target diagram encircles the goal values of these parameters,
ie, CI: 3l/min/m2, SaO2: 95%, MAP: 65 mm Hg, lactate: 2
mmol/L, and ScvO2: 70%. The scales for each parameter
were selected arbitrarily by the authors with reference to in-
ternational recommendations on hemodynamic goals.6 The
more the value of a parameter worsens, the more its place
on the target diagram moves away from the center. The tar-
get diagram is charted for a patient by joining together the
values of the 5 parameters. Thus, if the therapeutic goals are
achieved, the patient’s test values lie within the central cir-
cle.
The main aim of this preliminary descriptive study was
to evaluate over a 6-month period in our institution the ef-
fects of the use of this target diagram for developing un-
derstanding by the nursing team of the septic patient’s
hemodynamic status.
The second aim was to evaluate whether the systematic
use of the target diagram can improve goal completion. Fi-
nally, we analyze the relationship between the number of
goals reached at each time point and the patient’s outcome.
MATERIALS AND METHODS
Patients
After approval by our institution’s ethics committee,
during a 6-month period (from July to December 2005), all
patients with septic shock,2 mechanically ventilated; under
sedation; and having a central venous line, an arterial line,
and cardiac output monitoring with a PICCO™monitor
were included in the study and placed in an adult inten-
sive care unit of 16 beds in a university hospital.
Methods
Mean arterial pressure and ScvO2 were continuously
measured using an arterial catheter and pulse oxymetry; Hb
was measured every 12 hours; and blood lactate concen-
tration (mmol/L) was obtained from an arterial sample.
Central venous oxygen saturation was obtained from a sam-
ple taken from the central venous line in the superior vena
cava (position verified by X-ray, with the tip of the cath-
eter superimposed on the fourth right intercostal space, just
above the azygos cross). Cardiac index (CI) (L/min/m2) was
obtained using the PICCO™monitor by taking the average
of 3 transpulmonary thermodilution results.
There were no therapeutic instructions in the protocol.
All treatment decisions were at the discretion of the treat-
ing physician. MAP, CI, SaO2, ScvO2, and lactate measure-
ments were systematically made at 0, 6, 12, 24, 36, and 48
hours (H0, H6, H12, H24, H36, and H48), in addition to
those prescribed by the physician in charge of the patient.
These were then recorded by the nursing team on a target
diagram, a self-adhesive sticker placed on patient’s treat-
ment chart (Figures 1 and 2).
Figure 1 - The hemodynamic target diagram
Parameters of the target diagram and their scales: MAP (mean arterial
pressure): normal range, 65-80 mm Hg; CI (cardiac index): normal value > 3
L/min/m²; SaO2 (arterial oxygen saturation): normal range, 95%-99%;
Lactate, obtained from an arterial sample: normal value < 2 mmol/L; ScvO2
(central venous oxygen saturation): normal range > 70%; Hb (hemoglobin):
g/dL; NE (norepinephrine): mg/h.
The 5 parameters of the target diagram schematically represent oxygen delivery
(CI, SaO2), tissue perfusion (MAP), cellular ischemia (lactates), and oxygen
extraction (Scv O2). The central gray circle indicates the goal values of these
parameters. The more the value of a parameter worsens, the more its place on
the target diagram moves away from the center. The target area is drawn by
joining together the values of the 5 parameters. The more the surface area
represented by the 5 points is large and moves away from the gray circle, the
more the patient is hemodynamically unstable. One can then visually judge
adequacy between oxygen delivery (right side of the target diagram) and oxygen
consumption (left side of the target diagram).
Figure 2 - Evolution of the target area between H0 and H24 for a patient in
septic shock due to pneumonia: improvement of target parameters and reduction
in the norepinephrine administration starting from H12.
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All patients included were compared to a retrospective
control group including all the septic shock patients dur-
ing the 6 months before starting protocol (January to June
2005). Control and target groups were compared for age,
gender, Simplified Acute Physiology Score (SAPS II), di-
agnosis, mortality within 28 days, and number of lactate
and ScvO2 measurements.
In the target group, patients were split into survivors
and nonsurvivors according to the mortality at 28 days.
These two groups were compared regarding age, gender,
SAPS II score, diagnosis, and target parameters at H0, H6,
H12, H24, H36, and H48, as well as their average value
over the 48 hours of the study. The proportion of survivors
and nonsurvivors reaching the goal values of parameters
at each time point were also compared. We assessed the
nurses’ knowledge status prior to the introduction of target
diagram, implemented the new recording technique, and
then performed a post-test.
Questions before introduction of the target diagram were
as follows: 1- Describe the significance of an elevated lactate
concentration in patients with hypotension. 2- Describe the sig-
nificance of a low ScvO2h in patients with hypotension. 3-
Which parameters reflect a stable hemodynamic status?
Questions after the introduction of the target diagram
were as follows: 1- Describe the significance of an elevated
lactate concentration in patients with hypotension. 2- De-
scribe the significance of a low ScvO2 in patients with hy-
potension. 3- Which parameters reflect a stable hemodynamic
status? 4- Do you think it is interesting to use the target dia-
gram? 5- Does the target diagram help you to better under-
stand the hemodynamic profile of your patient? 6- Did the
use of the target diagram increase your work load?
Statistical analysis
Parameters were compared in the control and target pe-
riods, and in the survivors and the nonsurvivors of the tar-
get period using ANOVA or a nonparametric Mann-
Whitney U test when equality of variance was not met. Data
were expressed as mean ± standard deviation (SD). A P
value d•.05 was considered statistically significant.
RESULTS
Follow-up and evaluation of the use of the target
diagram by the nursing team
We received 39 questionnaires from the 42 nurses in the
unit before the target period and 41 after the target period.
Responses before versus after the introduction of the tar-
get diagram were, respectively, are summarized below:
• did not know the significance of an elevated lactate con-
centration in patients with hypotension, 49% versus
26% (P = .04);
• did not know the significance of a low ScvO2 in patients
with hypotension, 79% versus 30% (P < .01).
• did not know that macrocirculatory and microcircula-
tory parameters (lactates and ScvO2) are basic measure-
ments for hemodynamic assessment, 59% versus 15%
(P = .01).
Thirty-one (79%) believed the target diagram had
helped them to better understand the hemodynamic profile
of their patients and that the target diagram will help in
the earlier detection and thus the prevention of
hemodynamic instability. Most (82%) replied that it gave
them a more global view of the hemodynamic status of their
patients. Thirty-three (85%) said the target diagram did not
increase their workload. Sixty-seven percent of the nurses
were spontaneously using the target diagram and its param-
eters during nursing team hand-over meetings.
Characteristics of the patients during the target period
and the retrospective control period (Table 1)
In 2005, 80 patients were admitted to our unit for septic
shock: 42 during the control period and 38 during the tar-
get period. Control and target periods were comparable for
the number of patients, the SAPS II score, and the diagno-
sis. There was no significant difference in mortality between
the two groups. The mortality for these septic patients was
56%. The patients of the target period had significantly more
lactate and ScvO2 measurements than the patients of the con-
trol period (average number of measurements, respectively,
2.9 vs 5.5 for lactate and 0.2 vs 5.5 for ScvO2).
Table 1 - Characteristics of septic shock patients during the
2 periods. Demographic data, diagnosis, and number of blood
lactate and ScvO2 measurements.
Patients Controlperiod Target period P
N 42 38
Age (mean ± SD)* 58.4 ± 17.1 63.7 ± 13.7 .13
SAPS II (mean ± SD) 63.8 ± 19.7 59.9 ± 19.8 .37
Mortality D28 (n (%)) 25 (59) 20 (52) .1
Diagnosis
Pneumonia (n (%)) 17 (40) 13 (34) .56
Peritonitis (n (%)) 6 (14) 11 (28) .08
Urinary infection (n (%)) 2 (5) 1 (3) .62
Necrotizing fascitis (n (%)) 3 (7) 4 (11) .29
Hematological disease n (n (%)) 7 (17) 6 (16) .92
Other (n (%)) 7 (17) 3 (8) .24
Lactate measurements/patient (n (range)) 2.9 (1-6) 5.5 (2-6) .001
ScvO2 measurements/patient (n (range)) 0.2 (0-2) 5.5 (2-6) <.001
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Survivor and nonsurvivor characteristics during the
target period (Table 2)
During the protocol, 38 patients were included; 18 pa-
tients survived. Nonsurvivors were significantly older and
had significantly higher SAPS II scores than survivors. Four
patients died within the first 3 days, and 16 within the first
week. At the time of inclusion, all patients received nore-
pinephrine, and 7 (18%) of them also received dobutamine
within the first 2 days. There was no difference in the
number of patients who received dobutamine in the survi-
vor and nonsurvivor groups.
Comparison of target parameters between survivors
and nonsurvivors (Table 3 and 4)
Regarding numbers of measurements, 211 target meas-
urements were collected, with an average of 5.5 measure-
ments per patient (a maximum of 6); 96 measurements were
obtained in survivors and 115 in nonsurvivors. At H0, there
was no significant difference between survivors and
nonsurvivors for all target parameters: MAP, CI, SaO2, lac-
tate, ScvO2, hemoglobin, and norepinephrine infusion rate.
During the following 2 days, however, survivors had sig-
nificantly higher MAP and SaO2, as well as lower blood
lactate concentrations and norepinephrine infusion rates.
At H24, 46% of the survivors had reached all the goals
of the target vs only 10% of the nonsurvivors. This differ-
ence remained significant for the next 24 hours (Table 4).
DISCUSSION
The introduction of the target diagram was well ac-
cepted by the paramedical staff. The whole of the nursing
team pointed out the advantages of the target diagram for
the understanding of hemodynamic instability during sep-
tic shock. The relevance of linking the observation of usual
parameters (MAP, heart rate, urinary output, SaO2) with
those parameters reflecting peripheral tissue perfusion (lac-
tates, ScvO2) has been understood by them. According to
98% of the nursing team, the target diagram therefore
seemed to be a relevant and appropriate tool. They believe
that the target diagram will help them in the earlier detec-
tion and thus in the prevention of hemodynamic failure.
They appreciated the visual aspect of the tool, its ability
to be copied, and its simplicity (Figure 2).
The analysis of our practice during the 6 months be-
fore the introduction of the target diagram confirmed that,
in spite of physician knowledge of “early goal-directed
therapy” and the Surviving Sepsis Campaign, ScvO2 and
lactate measurements were not routinely performed in our
unit (Table 2). The usefulness of both parameters during
the early phase of septic shock has been proved,8–11 and their
measurement forms part of the guidelines in the Surviving
Sepsis Campaign.2 The use of the target diagram facilitated
the systematic measurement of these two parameters in our
unit; they are now considered essential for the septic pa-
tient and are included in the radar chart together with the
other usual parameters.
When all of the parameters of the target diagram are
considered together, our results show that the proportion
of patients “inside the target” (all the goals reached) was
significantly higher in survivors than in nonsurvivors from
H24 to H48 (H24: 46% vs 10%, P = .01; H36: 53% vs.
17%, P = .02; H48: 66% vs. 24%, P = .01) These differ-
ences are less remarkable if one examines the results on a
goal-by-goal basis (Table 4). This reinforces the advantage
of a tool giving a global view of parameters reflecting
macrocirculatory and microcirculatory function; it facilitates
the better appreciation of the patient’s hemodynamic sta-
tus (Figure 2). Hollenberg et al6 argue that clinicians treat-
ing septic patients should define specific goals and end
points, titrate therapies to those end points, and evaluate
the results of their interventions. With the target diagram,
we can use the radar chart to follow the performance of the
goal-directed therapy of septic patients. Our results show
that the number of goals reached during the first 2 days
are linked to the patient’s outcome (Table 4).
We chose the target parameters with reference to inter-
national recommendations on hemodynamic goals6 but also
to reflect both oxygen delivery (right side of the target dia-
gram) and oxygen tissue extraction and cellular ischemia (left
side of the target diagram) (Figure 1). Accordingly, it seems
to be an important point to have a visual assessment regard-
Table 2 - Demographic data, diagnosis, mortality rate, and
norepinephrine and dobutamine receiving during the first 2
days, comparing survivors and nonsurvivors of the target group.
Survivors Nonsurvivors P
n (%) 18 (48) 20 (52)
Age (mean ± SD) 58.5 ± 12.7 67.4 ± 13.5 .05
SASP II score (mean ± SD) 47.6 ± 12.4 68.8 ± 19.6 <.001
Diagnosis:
Pneumonia (n (%)) 5 (31) 8 (36) .74
Peritonitis (n (%)) 5 (31) 6 (27) .76
Urinary infection (n (%)) 0 (0) 1 (5) .38
Necrotizing fascitis (n (%)) 2 (12) 2 (9) .73
Hematological disease (n (%)) 3 (19) 3 (14) .66
Other (n (%)) 1 (7) 2 (9) .74
Mortality D3 (n (%)) / 6 (27)
Mortality D8 (n (%)) / 16 (73)
Mortality D28 (n (%)) / 22 (100)
Norepinephrine (n (%)) 16 (100) 22 (100) .98
Dobutamine (n (%)) 3 (18) 4 (18) .96
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ing oxygen delivery and consumption, as recommended by
Squara.12 For this reason, we included CI, SaO2, Hb, MAP,
ScvO2, and lactates, even if it is an imperfect image of the
DO2/VO2 ratio. The evolution of these parameters is variable
over the first 2 days, and so should be further evaluated (Ta-
ble 3). In any case, the concept of a target diagram as a moni-
toring tool is not fixed. The parameters included, their goal
levels, scales, and the frequency with which they are assayed
can evolve according to their utility, relevance, practicality,
and the developing evidence base. The introduction of the
target diagram was simple, and its use was readily accepted
by the nursing staff. This acceptance insured the continuous
use of this tool after the study period. The target concept has
revealed a way to involve all the medical and paramedical
staff in the care of septic patient. We are conscious that it is
not the only way, but in our ICU, it helped us to follow the
Table 3 - Target parameters in survivors and nonsurvivors: cardiac index (CI), arterial oxygen saturation (SaO2), mean
arterial blood pressure (MAP), blood lactate concentration, oxygen central venous saturation (ScvO2), norepinephrine
regimen, and hemoglobin concentration in survivors and nonsurvivors of the target group.
H0 H6 H12 H24 H36 H48 H0-H48
CI - L/min/m2
Survivors(range) 3.6 ± 0.6 3.9 ± 0.6 4 ± 0.6 4.2 ± 0.5 4.3 ± 0.55 4.3 ± 0.3 4.1 ± 0.4
(2.8-5.2) (2.8-5.6) (2.9-5.4) (3.2-5) (2.9-5) (3.7-5.2) (2.8-5.6)
Non-Survivors(range) 3.5 ± 1.1 3.6 ± 1.2 3.6 ± 1.1 3.6 ± 1.1 3.7 ± 1.1 3.8 ± 0.9 3.5 ± 1.1
(2.2-5.4) (2.1-5.4) (2-5.8) (2.2-5.6) (2.3-5.8) (2.2-5.7) (2-5.8)
P .78 .2 .2 .02 .05 .06 .06
SaO2 - %
Survivors(range) 96 ± 2 96 ± 2 96 ± 3 96 ± 2 97 ± 1 97 ± 2 96 ± 2
(90-99) (88-100) (90-100) (93-100) (94-99) (93-99) (88-100)
Nonsurvivors(range) 94 ± 3 94 ± 3 94 ± 3 94 ± 4 94 ± 4 94 ± 4 93 ± 4
(88-98) (86-99) (86-98) (86-99) (85-99) (85-98) (85-99)
P .09 .06 .04 .05 .09 .02 .01
MAP - mm Hg
Survivors(range) 65 ± 4 68 ± 7 71 ± 4 72 ± 4 73 ± 4 76 ± 3 72 ± 3
(58-75) (60-77) (65-78) (62-82) (63-79) (66-79) (58-82)
Non-Survivors(range) 63 ± 6 68 ± 3 67 ± 6 67 ± 8 69 ± 8 70* ± 6 65 ± 6
(55-75) (54-76) (52-78) (54-79) (56-85) (63-82) (52-85)
P .06 .2 .07 .08 .08 .03 .003
Lactate concentration mmol/L
Survivors(range) 3.6 ± 2.1 4.1 ± 2.1 3.2 ± 2.1 1.9 ± 1.1 1.8 ± 0.9 1.7 ± 0.7 2.7 ± 1.3
(1.7-7.1) (1.3-7.3) (0.8-7.0) (0.7-4.3) (0.6-4.2) (0.6-3.3) (0.6-7.3)
Nonsurvivors(range) 4.3 ± 3.3 4.7 ± 4.3 4.6 ± 3.6 6.2 ± 4.7 5.2 ± 4.5 4.7 ± 4.9 5.2 ± 3.5
(1.1-14.2) (1.5-16.8) (1.3-12.1) (1.1-16.4) (0.9-6.1) (0.9-17.5) (0.9-17.5)
P .48 .63 .18 .001 .007 .03 .02
ScvO2 - %
Survivors(range) 71 ± 8 75 ± 6 77 ± 6 76 ± 5 77 ± 6 78 ± 5 76 ± 4
(55-86) (66-89) (69-88) (67-85) (68-90) (67-85) (55-90)
Nonsurvivors(range) 71 ± 10 73 ± 8 73 ± 9 75 ± 10 76 ± 7 77 ± 7 72 ± 10
(53-90) (57-88) (60-90) (55-95) (65.92) (68-88) (55-95)
P .82 .28 .24 .88 .67 .9 .16
Norepinephrine mcg/kg/min
Survivors(range) 0.61 ± 0.2 0.57 ± 0.2 0.49 ± 0.2 0.39 ± 0.22 0.28 ± 0.2 0.2 ± 0.3 0.42 ± 0.2
(0.09-1.2) (0.13-1.1) (0.04-1) (0-0.93) (0.13-0.8) (0.04-1.2) (0-1.2)
Nonsurvivors(range) 0.78 ± 0.37 0.84 ± 0.36 0.75 ± 0.6 0.81 ± 0.7 0.49 ± 0.6 0.41 ± 0.5 0.68 ± 0.3
(0.31-1.4) (0.35-1.7) (0.2-2.23) (0-2.51) (0-2.11) (0-1.89) (0-2.51)
P .24 .02 .1 .03 .2 .3 .02
Hemoglobin - g/dL
Survivors(range) 10.5 ± 2.1 11.4 ± 1.2 11.2 ± 0.8 11.2 ± 0.5 11.2 ± 0.8 11 ± 0.7 11.1 ± 0.7
(6.7-13.5) (8.9-13) (9.5-13) (10.5-12) (9.8-12) (9.7-12.4) (6.7-13.5)
Nonsurvivors(range) 11 ± 2.3 11.3 ± 1.7 11.7 ± 1.1 11.1 ± 0.7 11.6 ± 1.2 10.8 ± 1.1 11.2 ± 1
(6.7-15.6) (8.8-14) (9.8-13.7) (9.5-12.4) (9.5-3.5) (9.3-13) (6.7-15.6)
P .5 .8 .7 .45 .3 .4 .8
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performance of goal-directed therapy. We think that the
visual concept of the tool, which can evolve, is an argument
for involving all the team.
However, we understand the limitations of our study,
as follows: a) being a prospective descriptive study with
no standardized therapy procedures and no therapeutic in-
structions, b) using a retrospective control group, c) includ-
ing only a few patients, and d) being only a monocentric
study, with the usefulness of the target diagram being as-
sessed only by 1 nursing department staff.
CONCLUSION
This observational study is preliminary, since it only
introduces a visual diagram of monitoring, without study-
ing the potential impact on patient outcome. However,
it has enabled us to detect deficiencies in the monitor-
ing of septic patients in our unit, ie, that ScvO2 and lac-
tate were not regularly monitored even in the early phase.
The introduction of the target diagram has facilitated the
inclusion of these two variables on the list of basic moni-
toring parameters for septic patients. Actually we are
considering another study with a therapeutic algorithm
to assess impact of the target diagram on septic patients’
outcomes.
The last phase of the Surviving Sepsis Campaign in-
volves translating the guidelines for septic patients in clini-
cal practice to create a global best practice for sepsis man-
agement.5,13 For hemodynamic support, the creation of a
multiparametric monitoring tool such as the target diagram
has revealed a way to educate and involve the nursing team
in this aim.
Table 4 - Proportion of patients reaching target goal value
at each time point:
survivors vs nonsurvivors.
H0 H6 H12 H24 H36 H48
patients with all target goals reached
Survivors (%) 12 34 34 46 53 66
Nonsurvivors (%) 4 12 9 10 17 24
P 0.06 0.13 0.08 0.01 0.02 0.01
patients with at least 4 target goals reached
Survivors (%) 41 60 87 86 86 93
Nonsurvivors (%) 4 36 55 55 53 65
P 0.05 0.2 0.03 0.03 0.04 0.05
patients with at least 3 target goals reached
Survivors (%) 74 100 100 100 100 100
Nonsurvivors (%) 43 86 80 80 82 83
P 0.07 0.08 0.07 0.07 0.1 0.15
patients with at least 2 target goals reached
Survivors (%) 100 100 100 100 100 100
Nonsurvivors (%) 81 86 88 80 82 83
P 0.08 0.08 0.2 0.07 0.1 0.15
patients with at least 1 target goal reached
Survivors (%) 100 100 100 100 100 100
Nonsurvivors (%) 96 91 88 90 88 84
P 0.4 0.14 0.21 0.21 0.17 0.08
RESUMO
Vallée F, Fourcade O, Marty F, Sanchez P, Samii K,
Genestal M. Alvo Hemodinâmico: uma ferramenta visual
de terapia “goal-directed” para pacientes sépticos. Clinics.
2007;62(4):447-54.
OBJETIVO: Melhorar a compreensão do “status”
hemodinâmico de pacientes em sepse pelas equipes de en-
fermagem através da obtenção de parâmetros hemodi-
nâmicos usando um diagrama-alvo pentaxial como ferra-
menta clínica. Os parâmetros usados foram índice cardía-
co, saturação arterial de oxigênio, pressão arterial media,
lactato sangüíneo arterial e saturação venosa central de oxi-
gênio.
MÉTODOS: Estudo descritivo prospectivo, realizado na
Unidade de Terapia Intensiva de um Hospital Universitá-
rio. Pacientes: Durante um período de 6 meses, 38 pacien-
tes intubados em choque séptico foram incluídos no estu-
do. Foram comparados sobreviventes vs. não sobreviven-
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tes. Intervenções: Os cinco parâmetros referidos foram me-
didos nas horas 0, 6, 12, 24, 36 e 48. As medidas foram
registradas no diagrama alvo, juntamente com a velocida-
de de infusão de norepinefrina e nível de hemoglobina. O
número de medidas de lactato e saturação venosa central
de oxigênio realizado durante o período de estudo foi com-
parado com um período retrospectivo de 6 meses imedia-
tamente precedendo a introdução do protocolo. Avaliamos
o nível de conhecimento das equipes de enfermagem an-
tes da introdução do diagrama-alvo. Após a realização do
protocolo realizamos uma nova avaliação.
MEDIDAS E RESULTADOS: A equipe de enfermagem
exprimiu uma atitude positiva em relação ao conceito de
diagrama alvo. O número de medidas de lactato e satura-
ção venosa central de oxigênio foi significativamente me-
nor durante o período controle anterior ao protocolo. E os
valores medidos raramente foram empregados como valo-
res meta antes da introdução do diagrama-alvo. Na medi-
da de 24 horas, 46% dos sobreviventes haviam atingido to-
das as metas do diagrama-alvo, contra apenas 10% dos não
sobreviventes (P = 0,01).
CONCLUSÃO. O diagrama-alvo é uma ferramenta visu-
al multiparamétrica envolvendo, as equipes médicas e de
enfermagem, que auxilia a obtenção de uma estratégia te-
rapêutica para pacientes sépticos. O número de valores
meta atingidos a cada momento durante as primeiras 48
horas relaciona-se à mortalidade
UNITERMOS: Diretrizes. Prática clínica. Pacientes
sépticos. Metas. Ferramenta alvo.
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